Figures computed from official regulatory filings — .
Insufficient history for a statistical track record (fewer than 5 open-market buys).
This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →
| Company | Type | Value · USD | Signals | Details | |
|---|---|---|---|---|---|
Summit Therapeutics Inc.Listing on record | AwardD (derivative) | n/a (No price was disclosed in the filing) | SEC | ||
Summit Therapeutics Inc.Listing on record | Buy | $10M | conv 66ClusterFirst in 12mo | SEC | |
Summit Therapeutics Inc.Listing on record | AwardD (derivative) | n/a (No price was disclosed in the filing) | SEC | ||
Summit Therapeutics Inc.Listing on record | AwardD (derivative) | $49.9K | SEC | ||
Summit Therapeutics Inc.Listing on record | Buy | $22.6M | conv 73Cluster | SEC | |
Summit Therapeutics Inc.Listing on record | Buy | $25.1M | conv 50First in 12mo | SEC | |
Summit Therapeutics Inc.Listing on record | AwardD (derivative) | n/a (No price was disclosed in the filing) | SEC | ||
Summit Therapeutics Inc.Listing on record | AwardD (derivative) | n/a (No price was disclosed in the filing) | SEC |